Over the past eight years, BIO’s semiannual IP Counsels Committee Conference has become a popular and growing event among our members’ IP and legal professionals. Our upcoming 2011 Spring IPCC Conference in Seattle, WA on April 13-15 will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP.
We invite you to join us in an informal, fun and informative setting to meet fellow in-house legal and IP professionals, to make new acquaintances, to reconnect with old friends in the industry, and to take home a wealth of information – and maybe some new ideas.
Session Titles:
1. Whose Rights are They, Anyway? Implications from and a Discussion on Stanford v. Roche
2. A Landmark Case: The Aftermath of Myriad
3. Best Practices in Research Collaborations: Joint Inventorship Pitfalls and Ethical Issues in Joint Representation
4. How to Stay in the Frying Pan and Out of the Fire: Hot Topics in Ethics for In-House IP Attorneys
5. Emerging Markets
6. Double Patenting
7. Biosimilars
Filed under: IP Counsels' Committee, Uncategorized | Tagged: BIO, biosimilars, biotechnology, Biotechnology Industry Organization, double patenting, emerging markets, Ethics for In-House IP Attorneys, intellectual property, Intellectual Property Counsels' Committee, IPCC, Myriad, Seattle, Stanford v. Roche | Leave a comment »
Patently BIOtech 